Fluctuations in NRXN1 levels and other neurexins are implicated in disrupting the balance of excitatory and inhibitory signals at synapses, resulting in damage and cognitive impairment seen early in AD [40]. This evidence concerns the gene NRXN1 and Alzheimer disease.